Skip to content

Randomised trial, 1999

Does alprazolam (an anti-anxiety medicine) affect how much women with PMDD eat?

Yes. Alprazolam increased food intake during the premenstrual phase, especially fatty foods. Women who restrict eating were most affected, eating 26% more calories on the highest dose than on placebo.

Early or limited evidence 19 women with PMDD

What they did

Studied 19 women with PMDD. Each woman received different doses of alprazolam (0, 0.25, 0.50, and 0.75 mg) once during the premenstrual phase and once during the postmenstrual phase. They rated food desires and ate lunch 3.5 hours after the medication.

What they found

Women wanted fatty foods more before their period than after. Alprazolam increased overall food intake during the premenstrual phase. Women who restrict eating ate 26% more calories on 0.75 mg alprazolam compared to placebo. Women who do not restrict eating ate 9% more calories.

What it means for you

Alprazolam may not be a good choice for women with PMDD who are concerned about weight, especially those who limit their eating. This is a small study of acute single doses, so results may not apply to long-term use.

19

Women studied

0.75 mg

Highest alprazolam dose tested

26%

More calories in restrained eaters on highest dose

About the study

Original title
Food "cravings" and the acute effects of alprazolam on food intake in women with premenstrual dysphoric disorder
Authors
Evans SM, Foltin RW, Fischman MW
Journal
Appetite
Year
1999
Study design
Randomised trial
Participants
19
What was tested
Alprazolam doses of 0.25 mg, 0.50 mg, and 0.75 mg vs placebo, tested during premenstrual and postmenstrual phases
Open access
Yes

Topics